Recall of Medtronic Minimed 640G Infusion Pump used in clinical trials

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Medtronic Australasia Pty Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Event ID
  • Event Risk Class
    Class II
  • Event Initiated Date
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    Medtronic has implemented an amendment to the pump user guide for medtronic minimed 640g insulin pumps. the change involves the bolus delivery accuracy listed in the pump user guide for very small bolus amounts (less than 0.1 u). delivery accuracy for bolus volumes < 0.1 unit is now updated to ±20%, from ±5%. the delivery accuracy for bolus volumes = 0.1 unit remains ±5%, as does the delivery accuracy for basal delivery.Medtronic considers that there is not likely to be any clinical risk associated with this change in delivery accuracy.
  • Action
    An update to the published Instructions for Use (IFU) regarding the stated resolution of the device at a dose of <0.1 Unit is to be circulated to customers. This action has been closed-out on 08/08/2016.


  • Model / Serial
    Medtronic Minimed 640G Infusion Pump used in clinical trialsModel Numbers: MMT-1511 & MMT-1512
  • Manufacturer


  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source